Reuters logo
BRIEF-Neovasc provides Tiara clinical update
September 12, 2017 / 11:28 AM / 2 months ago

BRIEF-Neovasc provides Tiara clinical update

Sept 12 (Reuters) - Neovasc Inc:

* Neovasc provides Tiara clinical update

* Neovasc Inc - ‍all cause, 30-day mortality in 33 patients who have reached 30 days post implant with Tiara is 12.1% (4/33) in Tiara trial​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below